Search results
AFWERX Selects Othram for SBIR Phase II Contract to Advance Forensic Intelligence Through Forensic...
PRWeb· 1 day ago...THE WOODLANDS, Texas, June 4, 2024 /PRNewswire-PRWeb/ -- Othram, the leading forensic sequencing laboratory for law enforcement, has been selected by AFWERX for a $1.25 million SBIR Phase II contract focused on advancing forensic DNA sequencing technology to address pressing challenges in the...
Ocugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why
Zacks· 16 hours agoFree Report) is having a phenomenal run in the year so far. Shares of the company have skyrocketed...
Second phase of Shepherd-Durham improvement project to continue with new compromise
Community Impact· 2 days agoWhitmire and the Memorial Heights Redevelopment Authority have reached a compromise on a project to...
Cullinan Therapeutics announces success for zipalertinib as combo therapy
Clinical Trials Arena via Yahoo Finance· 2 days agoCullinan Therapeutics has announced positive topline data from aPhase I/II trial of its pipeline...
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 3 days agoInterim safety and efficacy results of the Phase Ib/II Destiny-BREAST07 trial with Enhertu...
Seven-story building with 135 apartment units approved for Scioto Peninsula
WCMH via Yahoo News· 10 hours agoView a previous report where NBC4 toured the Scioto Peninsula’s Junto hotel in the video player...
Intellia (NTLA) Up on Upbeat Long-Term Angioedema Study Data
Zacks· 2 days agoIntellia (NTLA) gains 10% after reporting encouraging long-term efficacy data from the phase I portion of its early to mid-stage study evaluating NTLA-2002 for treating hereditary angioedema.
APAC leads in clinical trials for asthma during 2019-2023
Clinical Trials Arena via Yahoo Finance· 2 days agoPhase I trials comprised 42.4% of the total clinical trials. This was followed by Phase II (21.4%), ...
Novartis reports Phase III data for trials of remibrutinib to treat CSU
Clinical Trials Arena via Yahoo Finance· 5 days agoNo serious AEs reported were linked to the trial drug. Beyond CSU, remibrutinib is under...
Biden's legacy was born with D-Day. 80 years later, new challenges emerge on all fronts
USA TODAY via Yahoo News· 12 hours agoAll in the name of freedom. For the rest of his life, Biden’s view of the world and the United...